Public Profile

Guangzhou Pharmaceuticals Company Limited

Guangzhou Pharmaceuticals Company Limited, often referred to as GPC, is a leading player in the pharmaceutical industry, headquartered in Guangzhou, China. Established in 1997, GPC has made significant strides in the development and distribution of a wide range of pharmaceutical products, including traditional Chinese medicine, chemical drugs, and health supplements. With a strong operational presence across various regions in China and beyond, GPC is renowned for its commitment to quality and innovation. The company’s core offerings, which include both prescription and over-the-counter medications, are distinguished by their adherence to rigorous safety standards and advanced research methodologies. Recognised for its market leadership, Guangzhou Pharmaceuticals has achieved notable milestones, positioning itself as a trusted name in healthcare solutions. Its dedication to enhancing public health through effective and accessible products underscores its pivotal role in the pharmaceutical landscape.

DitchCarbon Score

How does Guangzhou Pharmaceuticals Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

14

Industry Benchmark

Guangzhou Pharmaceuticals Company Limited's score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Guangzhou Pharmaceuticals Company Limited's reported carbon emissions

Guangzhou Pharmaceuticals Company Limited, headquartered in CN, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). Additionally, there are no documented climate commitments or initiatives aimed at reducing greenhouse gas emissions. As the pharmaceutical industry increasingly focuses on sustainability, it is essential for companies like Guangzhou Pharmaceuticals to establish clear climate strategies and targets to align with global efforts in combating climate change.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Guangzhou Pharmaceuticals Company Limited's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Guangzhou Pharmaceuticals Company Limited is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Guangzhou Pharmaceuticals Company Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Zhejiang Int'l Medicine Co., Ltd.

CN
Chemicals nec
Updated 6 days ago

Wanjia Group Holdings Limited

HK
Chemicals nec
Updated 6 days ago

CHINA NATIONAL PHARMACEUTICAL GROUP

CN
Chemicals nec
Updated about 2 hours ago

Huadong Medicine Co., Ltd

CN
Chemicals nec
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers